Despite launching nearly two decades ago, worldwide sales of AbbVie's (NYSE: ABBV) lead drug, Humira still generates more revenue than most countries. As you can imagine, patent-protected exclusivity ...

AbbVie's growth prospects remain strong despite the impending decline in revenue from Humira, thanks to promising alternatives Skyrizi, Rinvoq, and the recently FDA-approved Linzess. The company's ...

Two of AbbVie's most important assets could get a lot harder to sell. Overcoming Humira's far-off patent losses has been central to AbbVie's existence for so long that it can be hard to realize ...

WASHINGTON — Boehringer Ingelheim is laying off or relocating its sales staff for its Humira biosimilar Cyltezo in a sign of how difficult it’s been to get drug middlemen to adopt less-expensive ...

Hair loss is a potential but uncommon side effect of Humira (adalimumab). Hair loss wasn’t reported during the drug’s studies, but has been reported since Humira was approved for use. Humira is a ...

June 7 (Reuters) - AbbVie’s (ABBV.N), opens new tab top-selling arthritis drug Humira has held onto more than 80% of patients after facing nine lower-priced rivals in the U.S. in the last year, ...

AbbVie is one of the largest global Pharmaceuticals, with a market cap of >$265bn. The company's lead asset - all-time best selling immunology drug Humira - finally loses patent protection this year ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The first Humira biosimilar hit the U.S. market a little ...

If you’re one of the millions of Americans taking the prescription medication Humira, get ready to add the word biosimilars to your conversations with your doctor. Starting July 1, alternatives to the ...

Stelara (ustekinumab) and Humira (adalimumab) are prescription drugs used to treat certain autoimmune or inflammatory conditions. Both are injectable biologic medications. This article explains the ...

If you’re one of the millions of Americans taking the prescription medication Humira, get ready to add the word biosimilars to your conversations with your doctor. Alternatives to the world’s ...